GO:0008793 | aromatic-amino-acid:2-oxoglutarate aminotransferase activity | 4.13% (5/121) | 6.41 | 0.0 | 0.0 |
GO:0047312 | L-phenylalanine:pyruvate aminotransferase activity | 4.13% (5/121) | 6.41 | 0.0 | 0.0 |
GO:0080097 | L-tryptophan:pyruvate aminotransferase activity | 4.13% (5/121) | 6.41 | 0.0 | 0.0 |
GO:0080098 | L-tyrosine:pyruvate aminotransferase activity | 4.13% (5/121) | 6.41 | 0.0 | 0.0 |
GO:0080099 | L-methionine:2-oxoglutarate aminotransferase activity | 4.13% (5/121) | 6.41 | 0.0 | 0.0 |
GO:0080100 | L-glutamine:2-oxoglutarate aminotransferase activity | 4.13% (5/121) | 6.41 | 0.0 | 0.0 |
GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity | 4.13% (5/121) | 6.41 | 0.0 | 0.0 |
GO:0050362 | L-tryptophan:2-oxoglutarate aminotransferase activity | 4.13% (5/121) | 6.34 | 0.0 | 1e-06 |
GO:0070546 | L-phenylalanine aminotransferase activity | 4.13% (5/121) | 6.34 | 0.0 | 1e-06 |
GO:0009683 | indoleacetic acid metabolic process | 5.79% (7/121) | 4.82 | 0.0 | 1e-06 |
GO:0009851 | auxin biosynthetic process | 5.79% (7/121) | 4.82 | 0.0 | 1e-06 |
GO:0070529 | L-tryptophan aminotransferase activity | 4.13% (5/121) | 6.27 | 0.0 | 1e-06 |
GO:0070548 | L-glutamine aminotransferase activity | 4.13% (5/121) | 6.2 | 0.0 | 1e-06 |
GO:0050048 | L-leucine:2-oxoglutarate aminotransferase activity | 4.13% (5/121) | 6.13 | 0.0 | 1e-06 |
GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity | 4.13% (5/121) | 5.96 | 0.0 | 1e-06 |
GO:0004838 | L-tyrosine:2-oxoglutarate aminotransferase activity | 4.13% (5/121) | 5.96 | 0.0 | 1e-06 |
GO:0047635 | alanine-oxo-acid transaminase activity | 4.13% (5/121) | 5.96 | 0.0 | 1e-06 |
GO:0010326 | methionine-oxo-acid transaminase activity | 4.13% (5/121) | 5.9 | 0.0 | 1e-06 |
GO:0070547 | L-tyrosine aminotransferase activity | 4.13% (5/121) | 5.9 | 0.0 | 1e-06 |
GO:0009684 | indoleacetic acid biosynthetic process | 5.79% (7/121) | 5.03 | 0.0 | 3e-06 |
GO:0031063 | regulation of histone deacetylation | 4.13% (5/121) | 5.45 | 0.0 | 7e-06 |
GO:0002021 | response to dietary excess | 3.31% (4/121) | 6.17 | 0.0 | 1.4e-05 |
GO:0045572 | positive regulation of imaginal disc growth | 3.31% (4/121) | 6.17 | 0.0 | 1.4e-05 |
GO:0050872 | white fat cell differentiation | 3.31% (4/121) | 6.17 | 0.0 | 1.4e-05 |
GO:0060613 | fat pad development | 3.31% (4/121) | 6.17 | 0.0 | 1.4e-05 |
GO:0045570 | regulation of imaginal disc growth | 3.31% (4/121) | 6.09 | 0.0 | 1.7e-05 |
GO:0008587 | imaginal disc-derived wing margin morphogenesis | 3.31% (4/121) | 5.88 | 1e-06 | 3.1e-05 |
GO:0031065 | positive regulation of histone deacetylation | 3.31% (4/121) | 5.75 | 1e-06 | 4.1e-05 |
GO:0090311 | regulation of protein deacetylation | 4.13% (5/121) | 4.85 | 1e-06 | 4.3e-05 |
GO:0090312 | positive regulation of protein deacetylation | 3.31% (4/121) | 5.69 | 1e-06 | 4.7e-05 |
GO:0009850 | auxin metabolic process | 5.79% (7/121) | 3.55 | 3e-06 | 0.00011 |
GO:0070050 | neuron cellular homeostasis | 3.31% (4/121) | 5.29 | 3e-06 | 0.000141 |
GO:0008483 | transaminase activity | 4.13% (5/121) | 4.45 | 4e-06 | 0.000146 |
GO:0016769 | transferase activity, transferring nitrogenous groups | 4.13% (5/121) | 4.43 | 4e-06 | 0.000151 |
GO:0060612 | adipose tissue development | 3.31% (4/121) | 5.21 | 4e-06 | 0.000164 |
GO:0022416 | chaeta development | 3.31% (4/121) | 5.17 | 5e-06 | 0.00017 |
GO:0061448 | connective tissue development | 3.31% (4/121) | 5.17 | 5e-06 | 0.00017 |
GO:0080022 | primary root development | 5.79% (7/121) | 3.42 | 5e-06 | 0.000176 |
GO:0045747 | positive regulation of Notch signaling pathway | 3.31% (4/121) | 5.13 | 5e-06 | 0.00018 |
GO:0090207 | regulation of triglyceride metabolic process | 3.31% (4/121) | 5.13 | 5e-06 | 0.00018 |
GO:0042461 | photoreceptor cell development | 3.31% (4/121) | 5.09 | 6e-06 | 0.000196 |
GO:0046329 | negative regulation of JNK cascade | 3.31% (4/121) | 5.01 | 7e-06 | 0.000236 |
GO:0042446 | hormone biosynthetic process | 6.61% (8/121) | 2.99 | 9e-06 | 0.000269 |
GO:0008022 | protein C-terminus binding | 4.96% (6/121) | 3.64 | 1e-05 | 0.000297 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 7.44% (9/121) | 2.71 | 1e-05 | 0.000316 |
GO:0045444 | fat cell differentiation | 3.31% (4/121) | 4.88 | 1.1e-05 | 0.000317 |
GO:0016846 | carbon-sulfur lyase activity | 4.13% (5/121) | 4.09 | 1.2e-05 | 0.000349 |
GO:0048527 | lateral root development | 6.61% (8/121) | 2.91 | 1.3e-05 | 0.000363 |
GO:0001835 | blastocyst hatching | 3.31% (4/121) | 4.78 | 1.4e-05 | 0.000366 |
GO:0035188 | hatching | 3.31% (4/121) | 4.78 | 1.4e-05 | 0.000366 |
GO:0071684 | organism emergence from protective structure | 3.31% (4/121) | 4.78 | 1.4e-05 | 0.000366 |
GO:0048467 | gynoecium development | 4.13% (5/121) | 4.06 | 1.3e-05 | 0.000371 |
GO:0043627 | response to estrogen | 3.31% (4/121) | 4.75 | 1.5e-05 | 0.000384 |
GO:0005819 | spindle | 5.79% (7/121) | 3.15 | 1.5e-05 | 0.000387 |
GO:0042435 | indole-containing compound biosynthetic process | 5.79% (7/121) | 3.14 | 1.6e-05 | 0.000392 |
GO:0008013 | beta-catenin binding | 3.31% (4/121) | 4.72 | 1.7e-05 | 0.000402 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 3.31% (4/121) | 4.69 | 1.8e-05 | 0.000421 |
GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 3.31% (4/121) | 4.69 | 1.8e-05 | 0.000421 |
GO:0048528 | post-embryonic root development | 6.61% (8/121) | 2.81 | 2.1e-05 | 0.000478 |
GO:0007605 | sensory perception of sound | 3.31% (4/121) | 4.61 | 2.3e-05 | 0.000505 |
GO:0050954 | sensory perception of mechanical stimulus | 3.31% (4/121) | 4.61 | 2.3e-05 | 0.000505 |
GO:0009723 | response to ethylene | 8.26% (10/121) | 2.39 | 2.4e-05 | 0.000521 |
GO:0090696 | post-embryonic plant organ development | 6.61% (8/121) | 2.73 | 3e-05 | 0.000651 |
GO:0008593 | regulation of Notch signaling pathway | 3.31% (4/121) | 4.45 | 3.5e-05 | 0.000737 |
GO:0034754 | cellular hormone metabolic process | 6.61% (8/121) | 2.68 | 3.8e-05 | 0.000796 |
GO:0046328 | regulation of JNK cascade | 3.31% (4/121) | 4.31 | 5.1e-05 | 0.001049 |
GO:0048438 | floral whorl development | 4.13% (5/121) | 3.64 | 5.5e-05 | 0.001111 |
GO:0043524 | negative regulation of neuron apoptotic process | 3.31% (4/121) | 4.27 | 5.8e-05 | 0.001147 |
GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 3.31% (4/121) | 4.23 | 6.5e-05 | 0.001269 |
GO:0017053 | transcription repressor complex | 3.31% (4/121) | 4.17 | 7.6e-05 | 0.001477 |
GO:1901184 | regulation of ERBB signaling pathway | 3.31% (4/121) | 4.11 | 9e-05 | 0.001685 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.48% (3/121) | 5.11 | 9e-05 | 0.001708 |
GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.48% (3/121) | 5.06 | 0.0001 | 0.0018 |
GO:0010078 | maintenance of root meristem identity | 4.13% (5/121) | 3.46 | 9.8e-05 | 0.0018 |
GO:0043562 | cellular response to nitrogen levels | 4.13% (5/121) | 3.46 | 9.8e-05 | 0.0018 |
GO:0010588 | cotyledon vascular tissue pattern formation | 4.13% (5/121) | 3.43 | 0.000108 | 0.001927 |
GO:0048545 | response to steroid hormone | 4.13% (5/121) | 3.4 | 0.000119 | 0.002088 |
GO:0035264 | multicellular organism growth | 3.31% (4/121) | 4.0 | 0.000121 | 0.002099 |
GO:0042430 | indole-containing compound metabolic process | 5.79% (7/121) | 2.68 | 0.000123 | 0.002106 |
GO:0005700 | polytene chromosome | 3.31% (4/121) | 3.98 | 0.000127 | 0.002146 |
GO:0047485 | protein N-terminus binding | 3.31% (4/121) | 3.96 | 0.000133 | 0.002222 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.65% (2/121) | 6.75 | 0.000141 | 0.002335 |
GO:0009641 | shade avoidance | 4.13% (5/121) | 3.32 | 0.000155 | 0.0025 |
GO:0030170 | pyridoxal phosphate binding | 4.13% (5/121) | 3.32 | 0.000155 | 0.0025 |
GO:0070279 | vitamin B6 binding | 4.13% (5/121) | 3.31 | 0.00016 | 0.002543 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | 3.31% (4/121) | 3.88 | 0.000167 | 0.002624 |
GO:0009958 | positive gravitropism | 4.13% (5/121) | 3.27 | 0.000184 | 0.002859 |
GO:2000469 | negative regulation of peroxidase activity | 2.48% (3/121) | 4.75 | 0.000192 | 0.00295 |
GO:0007289 | spermatid nucleus differentiation | 1.65% (2/121) | 6.53 | 0.000198 | 0.003006 |
GO:2000468 | regulation of peroxidase activity | 2.48% (3/121) | 4.71 | 0.000208 | 0.003098 |
GO:0009886 | post-embryonic animal morphogenesis | 3.31% (4/121) | 3.8 | 0.000206 | 0.003102 |
GO:0000118 | histone deacetylase complex | 3.31% (4/121) | 3.75 | 0.000233 | 0.003428 |
GO:0031404 | chloride ion binding | 1.65% (2/121) | 6.34 | 0.000263 | 0.003787 |
GO:0047654 | alliin lyase activity | 1.65% (2/121) | 6.34 | 0.000263 | 0.003787 |
GO:0030177 | positive regulation of Wnt signaling pathway | 3.31% (4/121) | 3.68 | 0.000283 | 0.004032 |
GO:0072686 | mitotic spindle | 3.31% (4/121) | 3.65 | 0.000305 | 0.0043 |
GO:0007423 | sensory organ development | 3.31% (4/121) | 3.62 | 0.000328 | 0.004533 |
GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.48% (3/121) | 4.49 | 0.000326 | 0.004553 |
GO:0048666 | neuron development | 3.31% (4/121) | 3.61 | 0.00034 | 0.004652 |
GO:0043409 | negative regulation of MAPK cascade | 3.31% (4/121) | 3.59 | 0.000353 | 0.004726 |
GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.48% (3/121) | 4.46 | 0.000349 | 0.004729 |
GO:0045927 | positive regulation of growth | 5.79% (7/121) | 2.4 | 0.000383 | 0.00509 |
GO:0051354 | negative regulation of oxidoreductase activity | 2.48% (3/121) | 4.4 | 0.000399 | 0.005239 |
GO:1901215 | negative regulation of neuron death | 3.31% (4/121) | 3.53 | 0.000419 | 0.005458 |
GO:0032872 | regulation of stress-activated MAPK cascade | 3.31% (4/121) | 3.52 | 0.000434 | 0.005591 |
GO:0031331 | positive regulation of cellular catabolic process | 5.79% (7/121) | 2.35 | 0.000484 | 0.006177 |
GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.65% (2/121) | 5.88 | 0.000513 | 0.006495 |
GO:0043523 | regulation of neuron apoptotic process | 3.31% (4/121) | 3.44 | 0.000527 | 0.006609 |
GO:0060249 | anatomical structure homeostasis | 3.31% (4/121) | 3.42 | 0.000561 | 0.006973 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 3.31% (4/121) | 3.39 | 0.000597 | 0.007349 |
GO:0009926 | auxin polar transport | 4.13% (5/121) | 2.88 | 0.000619 | 0.007483 |
GO:0031370 | eukaryotic initiation factor 4G binding | 1.65% (2/121) | 5.75 | 0.000615 | 0.007497 |
GO:0048639 | positive regulation of developmental growth | 4.13% (5/121) | 2.85 | 0.000685 | 0.00821 |
GO:0047434 | indolepyruvate decarboxylase activity | 1.65% (2/121) | 5.64 | 0.000725 | 0.008535 |
GO:0103075 | indole-3-pyruvate monooxygenase activity | 1.65% (2/121) | 5.64 | 0.000725 | 0.008535 |
GO:0007596 | blood coagulation | 1.65% (2/121) | 5.53 | 0.000844 | 0.009523 |
GO:0007599 | hemostasis | 1.65% (2/121) | 5.53 | 0.000844 | 0.009523 |
GO:0050817 | coagulation | 1.65% (2/121) | 5.53 | 0.000844 | 0.009523 |
GO:0007600 | sensory perception | 3.31% (4/121) | 3.27 | 0.000823 | 0.009602 |
GO:0019842 | vitamin binding | 4.13% (5/121) | 2.79 | 0.000833 | 0.009645 |
GO:0042445 | hormone metabolic process | 6.61% (8/121) | 2.0 | 0.000945 | 0.010569 |
GO:0060828 | regulation of canonical Wnt signaling pathway | 3.31% (4/121) | 3.17 | 0.001075 | 0.011928 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 10.74% (13/121) | 1.42 | 0.00119 | 0.013099 |
GO:0031047 | gene silencing by RNA | 4.13% (5/121) | 2.66 | 0.001221 | 0.013227 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.31% (4/121) | 3.12 | 0.001219 | 0.013313 |
GO:0003714 | transcription corepressor activity | 3.31% (4/121) | 3.1 | 0.001281 | 0.013762 |
GO:0016829 | lyase activity | 7.44% (9/121) | 1.77 | 0.001395 | 0.014875 |
GO:0048599 | oocyte development | 1.65% (2/121) | 5.17 | 0.001408 | 0.01489 |
GO:0009896 | positive regulation of catabolic process | 5.79% (7/121) | 2.05 | 0.00162 | 0.017008 |
GO:2000060 | positive regulation of ubiquitin-dependent protein catabolic process | 3.31% (4/121) | 2.98 | 0.001734 | 0.018055 |
GO:0060212 | negative regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.65% (2/121) | 4.94 | 0.00192 | 0.01955 |
GO:1900152 | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.65% (2/121) | 4.94 | 0.00192 | 0.01955 |
GO:0043408 | regulation of MAPK cascade | 4.13% (5/121) | 2.52 | 0.001898 | 0.019619 |
GO:0019827 | stem cell population maintenance | 5.79% (7/121) | 1.97 | 0.002209 | 0.02232 |
GO:0098727 | maintenance of cell number | 5.79% (7/121) | 1.95 | 0.002385 | 0.023742 |
GO:0048513 | animal organ development | 8.26% (10/121) | 1.55 | 0.002375 | 0.02382 |
GO:0051341 | regulation of oxidoreductase activity | 2.48% (3/121) | 3.49 | 0.002456 | 0.024271 |
GO:1901214 | regulation of neuron death | 3.31% (4/121) | 2.83 | 0.002529 | 0.024814 |
GO:0060918 | auxin transport | 4.13% (5/121) | 2.4 | 0.002663 | 0.025942 |
GO:0008494 | translation activator activity | 1.65% (2/121) | 4.69 | 0.002721 | 0.026318 |
GO:0031058 | positive regulation of histone modification | 3.31% (4/121) | 2.77 | 0.002896 | 0.027815 |
GO:0048601 | oocyte morphogenesis | 0.83% (1/121) | 8.34 | 0.003096 | 0.028708 |
GO:0060278 | regulation of ovulation | 0.83% (1/121) | 8.34 | 0.003096 | 0.028708 |
GO:0060280 | negative regulation of ovulation | 0.83% (1/121) | 8.34 | 0.003096 | 0.028708 |
GO:0140610 | RNA sequestering activity | 0.83% (1/121) | 8.34 | 0.003096 | 0.028708 |
GO:1901800 | positive regulation of proteasomal protein catabolic process | 3.31% (4/121) | 2.74 | 0.003122 | 0.028757 |
GO:0010074 | maintenance of meristem identity | 4.96% (6/121) | 2.09 | 0.003037 | 0.028956 |
GO:0019010 | farnesoic acid O-methyltransferase activity | 1.65% (2/121) | 4.58 | 0.003171 | 0.029011 |
GO:0048364 | root development | 8.26% (10/121) | 1.47 | 0.003437 | 0.031232 |
GO:0030111 | regulation of Wnt signaling pathway | 3.31% (4/121) | 2.7 | 0.003483 | 0.031436 |
GO:0009900 | dehiscence | 3.31% (4/121) | 2.66 | 0.00387 | 0.034704 |
GO:1990124 | messenger ribonucleoprotein complex | 1.65% (2/121) | 4.43 | 0.003906 | 0.034796 |
GO:0031056 | regulation of histone modification | 4.13% (5/121) | 2.26 | 0.00407 | 0.03602 |
GO:0009888 | tissue development | 9.09% (11/121) | 1.35 | 0.004168 | 0.036407 |
GO:0030749 | loganate O-methyltransferase activity | 1.65% (2/121) | 4.38 | 0.004167 | 0.036638 |
GO:0009630 | gravitropism | 4.13% (5/121) | 2.24 | 0.004384 | 0.038047 |
GO:1903052 | positive regulation of proteolysis involved in protein catabolic process | 3.31% (4/121) | 2.59 | 0.004505 | 0.038854 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.31% (4/121) | 2.58 | 0.004655 | 0.039894 |
GO:0035194 | post-transcriptional gene silencing by RNA | 2.48% (3/121) | 3.14 | 0.004908 | 0.041535 |
GO:0016831 | carboxy-lyase activity | 2.48% (3/121) | 3.14 | 0.004908 | 0.041535 |
GO:0051253 | negative regulation of RNA metabolic process | 9.09% (11/121) | 1.31 | 0.004978 | 0.041861 |
GO:0010256 | endomembrane system organization | 1.65% (2/121) | 4.13 | 0.005897 | 0.048982 |
GO:0072330 | monocarboxylic acid biosynthetic process | 5.79% (7/121) | 1.71 | 0.005882 | 0.049165 |
GO:0010917 | negative regulation of mitochondrial membrane potential | 0.83% (1/121) | 7.34 | 0.006182 | 0.049526 |
GO:0045837 | negative regulation of membrane potential | 0.83% (1/121) | 7.34 | 0.006182 | 0.049526 |
GO:0047254 | 2,4-dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one 2-D-glucosyltransferase activity | 0.83% (1/121) | 7.34 | 0.006182 | 0.049526 |
GO:0051078 | meiotic nuclear membrane disassembly | 0.83% (1/121) | 7.34 | 0.006182 | 0.049526 |
GO:0062104 | pumilio-response element binding | 0.83% (1/121) | 7.34 | 0.006182 | 0.049526 |
GO:0036158 | outer dynein arm assembly | 0.83% (1/121) | 7.34 | 0.006182 | 0.049526 |